close
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Lobe Sciences Ltd.

Lobe Sciences and Alera Pharma Announce Notice of Allowance for Second U.S. Patent for Conjugated Psilocin™
From Lobe Sciences Ltd.
Via Business Wire
Tickers CSE:LOBE LOBEF
Lobe Sciences Announces Update
From Lobe Sciences Ltd.
Via Business Wire
Tickers CSE:LOBE LOBEF
Wesley Ramjeet to Join Lobe Sciences’ Board of Directors, Bringing Decades of Strategic Financial Expertise
From Lobe Sciences Ltd.
Via Business Wire
Tickers CSE:LOBE LOBEF
Lobe Sciences Announces Frederick D. Sancilio Ph.D. to Join Board of Directors
From Lobe Sciences Ltd.
Via Business Wire
Tickers CSE:LOBE LOBEF
Former Merck Director and Vanderbilt Vice-Chancellor, Dr. Harry Jacobson, to Join Lobe Sciences Board of Directors
From Lobe Sciences Ltd.
Via Business Wire
Tickers CSE:LOBE LOBEF
Lobe Sciences Ltd. and Clearway Global Announce Change of Control and Focus on Creating Value for Shareholders
From Lobe Sciences Ltd.
Via Business Wire
Tickers CSE:LOBE LOBEF
Lobe Sciences Provides Company Review of 2023
From Lobe Sciences Ltd.
Via Business Wire
Tickers CSE:LOBE LOBEF
Lobe Sciences Provides Update on L-130 Clinical Program
From Lobe Sciences Ltd.
Via Business Wire
Tickers CSE:LOBE LOBEF
Lobe Sciences Provides Update on L-130 Oral Psilocin Compound
From Lobe Sciences Ltd.
Via Business Wire
Tickers CSE:LOBE LOBEF
Lobe Sciences, Ltd. Announces Amendment to the Acquisition of Altemia™ & Company
From Lobe Sciences Ltd.
Via Business Wire
Tickers CSE:LOBE LOBEF
Lobe Sciences Initiates Phase 1 Clinical Trial of L-130
From Lobe Sciences Ltd.
Via Business Wire
Tickers CSE:LOBE LOBEF
Lobe Sciences Appoints Baxter Phillips III, MBA as Chief Operating Officer
From Lobe Sciences Ltd.
Via Business Wire
Tickers CSE:LOBE LOBEF
Lobe Sciences Announces Commercial Distribution Agreement With Pentec Health for US Launch of Altemia™
From Lobe Sciences Ltd.
Via Business Wire
Tickers CSE:LOBE LOBEF
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Starting at $3.75/week.

Subscribe Today